Zobrazeno 1 - 7
of 7
pro vyhledávání: '"D A, Pliskevych"'
Publikováno v:
Likars'ka sprava. (4)
Silent myocardial ischemia (SMI) is a poor prognostic sign of cardiac events development, such as myocardial infarction and sudden cardiac death. This article presents the last decade research findings dedicated exploring mechanisms of SMI developmen
Autor:
V H, Lyzogub, T V, Zaval's'ka, L A, Stakhurs'ka, Khalied Akhmad Khalil, Abu Sara, D A, Pliskevych, V I, Dunaievs'kyĭ, B P, Grubnik
Publikováno v:
Likars'ka sprava. (5)
Violations gumoralis and cellular immunity examine as one of anchormen of pathogenetic mechanisms development of ischemic heart trouble. These literatures over, that testifying to development of disbalance of subpopulations of T- and B-lymphocitis, a
Publikováno v:
Likars'ka sprava. (7-8)
The article is devoted to the study of metabolism of polynonsaturated fat acids in a human body as antiatherogenous which prevents the development of cardiovascular diseases (ischemic heart disease, hypertension), as well as oncological diseases, a p
Publikováno v:
Likars'ka sprava. (8)
Cardio-vascular diseases and acute coronary syndrome (ACS) in the first place play the first role in the structure of diseases and mortality of world population. Effective method of diagnostics of ACS consists in detecting early and late biomarkers o
Publikováno v:
Likars'ka sprava. (5-6)
We have studied the influence of Etmosin medication on severity of IHD clinical presentations and comprised biliary motility in 162 patients aged 26 to 60. Dynamic echocholecystography (DECG) has been applied. The obtained data suggest using Etmosin
Publikováno v:
Likars'ka sprava. (3-4)
Heart syndrome features associated with pain, the structure of myocardial ischemia and heart rate derangement were studied in patients with ischemic heart disease (IHD) and concomitant biliary dyskinesia (BD). It was established that BD considerably
Publikováno v:
Likars'ka sprava. (2)
Corinfar-Retard efficacy in patients with hypertonic-hyperkinetic type of biliary dyskinesia has been studied. 56 patients aged 26 to 30 had been prescribed Corinfar-Retard in 20 mg per day for 7 days. Dynamic echocholecystography has applied. Decrea